Brian W. Behm, MD MHS
Brian Behm MD MHS
PRIMARY APPOINTMENT
Assistant Professor, Medicine
Contact
PO Box 800708
Charlottesville, Virginia 22908
Telephone: 434-243-9309
Fax: 434-244-7527
EDUCATION
- Fellowship, Gastroenterology, University of Virginia
- MD, Medicine, University of Virginia
- Residency, Internal Medicine, University of California San Francisco
- BA, Cornell University
RESEARCH AREAS
Inflammatory bowel disease (IBD), Crohn’s disease, ulcerative colitis, chronic diarrhea, pouchitis, and other disorders of ileoanal pouch, ulcerative proctitis.
RESEARCH SUMMARY
Dr. Behm’s research interests include understanding the pathogenesis of intestinal inflammation, noninvasive imaging of the small and large intestine, and translational and clinical research studying potential new therapies for inflammatory bowel disease. He is currently studying the role of statins in decreasing intestinal inflammation in patients with Crohn’s disease. He is active in several clinical trials evaluating new therapies for ulcerative colitis and Crohn’s disease.
2021
Jain, V., Behm, B., & Figueroa, E. (2021). P022 Biologic Therapy and Therapeutic Drug Monitoring in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.. The American journal of gastroenterology, 116(Suppl 1), S5. doi:10.14309/01.ajg.0000798688.16985.68
Jan, N., Hays, R. A., Oakland, D. N., Kumar, P., Ramakrishnan, G., Behm, B. W., . . . Marie, C. (2021). Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile. MSPHERE, 6(5). doi:10.1128/mSphere.00669-21
2020
Tyler, C. J., Guzman, M., Lundborg, L. R., Yeasmin, S., Perez-Jeldres, T., Yarur, A., . . . Rivera-Nieves, J. (2020). Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design. JOURNAL OF CROHNS & COLITIS, 14(10), 1364-1377. doi:10.1093/ecco-jcc/jjaa067
Auerbach, M., Behm, B. W., & Sankineni, A. (2020). Treatment of Iron Deficiency in Gastroenterology: A New Paradigm. PRACTICAL GASTROENTEROLOGY, 44(1), 18-25. Retrieved from https://www.webofscience.com/
2019
Wang, J., Nakamura, T. I., Tuskey, A. G., & Behm, B. W. (2019). Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study. INTESTINAL RESEARCH, 17(4), 496-503. doi:10.5217/ir.2019.00050
Chitnavis, M. V., Baray, M., Northup, P. G., Tuskey, A. G., & Behm, B. W. (2019). Opioid use and misuse in ulcerative colitis. World journal of gastrointestinal pharmacology and therapeutics, 10(1), 22-28. doi:10.4292/wjgpt.v10.i1.22
2018
Wentworth, B. J., Buerlein, R. C. D., Tuskey, A. G., Overby, M. A., Smolkin, M. E., & Behm, B. W. (2018). Nonadherence to Biologic Therapies in Inflammatory Bowel Disease. INFLAMMATORY BOWEL DISEASES, 24(9), 2053-2061. doi:10.1093/ibd/izy102
Stine, J. G., Wang, J., Cornella, S. L., Behm, B. W., Henry, Z., Shah, N. L., . . . Northup, P. G. (2018). Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial. Annals of hepatology, 17(2), 300-306. doi:10.5604/01.3001.0010.8661
Niccum, B. A., Stein, D. J., Behm, B. W., & Hays, R. A. (2018). Zinc Deficiency and the Recurrence of Clostridium difficile Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study. JOURNAL OF NUTRITION AND METABOLISM, 2018. doi:10.1155/2018/9682975
Stine, J. G., Wang, J., Cornelia, S. L., Behm, B. W., Henry, Z., Shah, N. L., . . . Northup, P. G. (2018). Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial. ANNALS OF HEPATOLOGY, 17(2), 300-306. doi:10.5604/01.3001.0010.8661
2017
Copland, A. P., Behm, B., & Parrish, C. R. (2017). Seeking Enteral Autonomy with Teduglutide. PRACTICAL GASTROENTEROLOGY, 41(9), 41-52. Retrieved from https://www.webofscience.com/
Chitnavis, M., Stein, D. J., Commins, S., Schuyler, A. J., & Behm, B. (2017). First-dose anaphylaxis to infliximab: a case of mammalian meat allergy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 5(5), 1425-1426. doi:10.1016/j.jaip.2017.04.044
2016
deFonseka, A. M., Tuskey, A., Conaway, M. R., & Behm, B. W. (2016). Antitumor Necrosis Factor-alpha Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(7), 578-583. doi:10.1097/MCG.0000000000000408
Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., . . . PREVENT Study Group. (2016). Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection.. Gastroenterology, 150(7), 1568-1578. doi:10.1053/j.gastro.2016.02.072
Stine, J. G., Wang, J., & Behm, B. W. (2016). Chronic Cholestatic Liver Injury Attributable to Vedolizumab. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 4(3), 277-280. doi:10.14218/JCTH.2016.00018
2015
Mosli, M. H., MacDonald, J. K., Bickston, S. J., Behm, B. W., Tsoulis, D. J., Cheng, J., . . . Feagan, B. G. (2015). Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis. INFLAMMATORY BOWEL DISEASES, 21(5), 1151-1159. doi:10.1097/MIB.0000000000000396
2014
Crocker, J. A., Yu, H., Conaway, M., Tuskey, A. G., & Behm, B. W. (2014). Narcotic Use and Misuse in Crohn’s Disease. INFLAMMATORY BOWEL DISEASES, 20(12), 2234-2238. doi:10.1097/MIB.0000000000000194
Bickston, S. J., Behm, B. W., Tsoulis, D. J., Cheng, J., MacDonald, J. K., Khanna, R., & Feagan, B. G. (2014). Vedolizumab for induction and maintenance of remission in ulcerative colitis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (8). doi:10.1002/14651858.CD007571.pub2
Tuskey, A., & Behm, B. W. (2014). Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn’s disease. CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 7, 173-179. doi:10.2147/CEG.S39518
2013
Tekola, B. D., Arner, D. M., & Behm, B. W. (2013). Coil migration after transarterial coil embolization of a splenic artery pseudoaneurysm.. Case reports in gastroenterology, 7(3), 487-491. doi:10.1159/000357151
2012
McConnell, J., Parvulescu-Codrea, S., Behm, B., Hill, B., Dunkle, E., Finke, K., . . . Woodward, B. (2012). Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness.. World journal of gastrointestinal pharmacology and therapeutics, 3(5), 74-82. doi:10.4292/wjgpt.v3.i5.74
2011
Behm, B. W., & Peura, D. A. (2011). Dexlansoprazole MR for the management of gastroesophageal reflux disease. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 5(4), 439-445. doi:10.1586/EGH.11.37
Wang, A. Y., Sauer, B. G., Behm, B. W., Ramanath, M., Cox, D. G., Ellen, K. L., . . . Kahaleh, M. (2011). Single-balloon or short double-balloon enteroscopy for ERCP in patients with surgically altered anatomies Response. GASTROINTESTINAL ENDOSCOPY, 73(2), 416-417. doi:10.1016/j.gie.2010.07.021
2010
Wang, A. Y., Sauer, B. G., Behm, B. W., Ramanath, M., Cox, D. G., Ellen, K. L., . . . Kahaleh, M. (2010). Single-balloon enteroscopy effectively enables diagnostic and therapeutic retrograde cholangiography in patients with surgically altered anatomy. GASTROINTESTINAL ENDOSCOPY, 71(3), 641-649. doi:10.1016/j.gie.2009.10.051